KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Emergent BioSolutions (EBS) Inventory Average: 2011-2024

Historic Inventory Average for Emergent BioSolutions (EBS) over the last 14 years, with Dec 2024 value amounting to $320.3 million.

  • Emergent BioSolutions' Inventory Average rose 8.54% to $347.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $347.4 million, marking a year-over-year increase of 8.54%. This contributed to the annual value of $320.3 million for FY2024, which is 5.74% down from last year.
  • Per Emergent BioSolutions' latest filing, its Inventory Average stood at $320.3 million for FY2024, which was down 5.74% from $339.8 million recorded in FY2023.
  • In the past 5 years, Emergent BioSolutions' Inventory Average registered a high of $347.6 million during FY2022, and its lowest value of $264.8 million during FY2020.
  • Moreover, its 3-year median value for Inventory Average was $339.8 million (2023), whereas its average is $335.9 million.
  • As far as peak fluctuations go, Emergent BioSolutions' Inventory Average rose by 23.63% in 2020, and later dropped by 5.74% in 2024.
  • Yearly analysis of 5 years shows Emergent BioSolutions' Inventory Average stood at $264.8 million in 2020, then increased by 23.04% to $325.8 million in 2021, then climbed by 6.71% to $347.6 million in 2022, then dropped by 2.24% to $339.8 million in 2023, then dropped by 5.74% to $320.3 million in 2024.